Ginette Vallieres Email

Coordonnatrice - relations avec les investisseurs . Aeterna Zentaris

Current Roles

Employees:
41
Revenue:
$1.7M
About
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. The company’s product pipeline includes MACRILEN, which completed the Phase 2 trial for use in the diagnosis of adult growth hormone deficiency; and zoptarelin doxorubicin, which is in Phase 3 clinical study zoptarelin doxorubicin in endometrial cancer (ZoptEC) of the compound in women with advanced, recurrent, or metastatic endometrial cancer. It is also developing two oncology compounds, including an Erk inhibitor and luteinizing hormone-releasing hormone-disorazol Z product candidates, which are in pre-clinical development. Aeterna Zentaris Inc. was founded in 1991 and is headquartered in Quebec City, Canada.
Aeterna Zentaris Address
315 Sigma Drive
Summerville, SC
United States
Aeterna Zentaris Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.